Science Explorer Back to mapMap

Most cited papers from Geisinger Health System

What are the most cited papers from Geisinger Health System?

The most cited paper from Geisinger Health System is "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (Daniel J. Klionsky et al., 2016), with 6,023 citations. Next come "Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals" (2,896) and "Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America" (2,793).

Showing 50 of 60 papers. Every paper with more than 720 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
2 Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals James J. Lee et al. · Nature Genetics Open access 20 Jul 2018 2,896
3 Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America Dennis Leroy Stevens, Alan L. Bisno, Henry F. “Chip” Chambers et al. · Clinical Infectious Diseases 19 Jun 2014 2,793
4 Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma Roger Stupp et al. · JAMA Open access 19 Dec 2017 2,699
5 ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Robert C. Green, Jonathan S. Berg, Wayne W. Grody et al. · Genetics in Medicine Open access 20 Jun 2013 2,580
6 Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs S Hong Lee et al. · Nature Genetics Open access370 authors 11 Aug 2013 2,374
7 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors 30 Dec 2021 2,100
8 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) Erin Rooney Riggs, Erica Andersen, Athena M. Cherry et al. · Genetics in Medicine Open access 5 Nov 2019 1,854
9 Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics Sarah S. Kalia, Kathy Adelman, Sherri J. Bale et al. · Genetics in Medicine Open access 17 Nov 2016 1,725
10 Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes Steven E. Nissen, Taro Tsunoda, Emin Murat Tuzcu et al. · JAMA Open access 4 Nov 2003 1,710
11 Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce Walter F. Stewart · JAMA 11 Nov 2003 1,590
12 ClinGen — The Clinical Genome Resource Heidi L. Rehm, Jonathan S. Berg, Lisa Brooks et al. · New England Journal of Medicine Open access 27 May 2015 1,587
13 Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci Stephan Sanders et al. · Neuron Open access Sep 2015 1,576
14 Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Susan L Hyman et al. · PEDIATRICS 16 Dec 2019 1,541
15 Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America Dennis Leroy Stevens, Alan L. Bisno, Henry F. “Chip” Chambers et al. · Clinical Infectious Diseases Open access 27 Jun 2014 1,540
16 Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Caroline S. Fox, Kunihiro Matsushita, Mark Woodward et al. · The Lancet ReviewOpen access 23 Sep 2012 1,413
17 Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen et al. · The Journal of Clinical Endocrinology & Metabolism Open access 15 Jan 2015 1,346
18 Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism Stephan Sanders et al. · Neuron Open access Jun 2011 1,307
19 Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma Roger Stupp et al. · JAMA Open access 15 Dec 2015 1,256
20 Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis Jacob Selhub, Paul F. Jacques, Andrew G. Bostom et al. · New England Journal of Medicine 2 Feb 1995 1,230
21 Do “Brain-Training” Programs Work? Daniel J. Simons, Walter R. Boot, Neil H. Charness et al. · Psychological Science in the Public Interest Oct 2016 1,211
22 Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence Raju Kumar Vaddepally, Prakash Kharel, Ramesh Kumar Pandey et al. · Cancers Open access 20 Mar 2020 1,208
23 Development and Validation of the American Heart Association’s PREVENT Equations Sadiya S. Khan et al. · Circulation Open access 10 Nov 2023 1,154
24 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
25 The power of genetic diversity in genome-wide association studies of lipids Sarah E. Graham et al. · Nature Open access527 authors 9 Dec 2021 1,099
26 SLC24A5, a Putative Cation Exchanger, Affects Pigmentation in Zebrafish and Humans Rebecca L. Lamason et al. · Science 15 Dec 2005 1,076
27 Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale Anthony J. Furlan, Mark Reisman, Joseph M. Massaro et al. · New England Journal of Medicine 14 Mar 2012 1,067
28 Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis Shanshan Chu, Richard C. Becker, Peter B. Berger et al. · Journal of Thrombosis and Haemostasis ReviewOpen access 19 Aug 2009 1,060
29 Neuroinvasion of SARS-CoV-2 in human and mouse brain Eric J. Song et al. · The Journal of Experimental Medicine Open access 11 Dec 2020 1,046
30 Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality Josef Coresh et al. · JAMA Open access 3 Jun 2014 1,004
31 Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls Mohammad R. Arbabshirani, Sergey Plis, Jing Sui (Beijing Normal University), my correct affiliation is beijing normal u et al. · NeuroImage Open access 21 Mar 2016 968
32 Biobank-driven genomic discovery yields new insight into atrial fibrillation biology Jonas Bille Nielsen et al. · Nature Genetics Open access 26 Jul 2018 951
33 A catalog of genetic loci associated with kidney function from analyses of a million individuals Lifelines Cohort Study et al. · Nature Genetics Open access329 authors 31 May 2019 946
34 Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure Sonia H Shah et al. · Nature Communications Open access203 authors 9 Jan 2020 944
35 A saturated map of common genetic variants associated with human height Loïc Yengo et al. · Nature Open access632 authors 12 Oct 2022 934
36 Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology Andrew E. Clark, Erin J. Kaleta, Amit Arora et al. · Clinical Microbiology Reviews Open access Jul 2013 931
37 Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke David Sacks et al. · International Journal of Stroke Open access 22 May 2018 917
38 Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease Frederick E. Dewey et al. · New England Journal of Medicine Open access 24 May 2017 905
39 The influence of lipophilicity in drug discovery and design John A. Arnott, Sonia Lobo Planey · Expert Opinion on Drug Discovery 19 Sep 2012 874
40 Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors Bernard Fisher et al. · JNCI Journal of the National Cancer Institute 6 Nov 1996 871
41 Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences Richard Karlsson Linnér et al. · Nature Genetics Open access 9 Jan 2019 857
42 Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Samuel Zachary Goldhaber, Patricia C. Come, R.T. Lee et al. · The Lancet Feb 1993 854
43 Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Daniel H. O’Leary, Joseph F. Polak, Richard A. Kronmal et al. · Stroke Open access Dec 1992 847
44 Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline Michael A. Vogelbaum et al. · Journal of Clinical Oncology Open access 21 Dec 2021 844
45 The Perioperative Management of Antithrombotic Therapy James Demetrios Douketis, Peter B. Berger, Andrew S Dunn et al. · CHEST Journal Jun 2008 836
46 A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease Noura S. Abul‐Husn et al. · New England Journal of Medicine Open access 21 Mar 2018 835
47 The built environment and obesity: A systematic review of the epidemiologic evidence Jing Bo Feng, Thomas A. Glass, Frank C. Curriero et al. · Health & Place Review 4 Oct 2009 817
48 Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways Colm T. O'Dushlaine et al. · Nature Neuroscience Open access375 authors 19 Jan 2015 807
49 Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Deepak L. Bhatt et al. · Journal of the American College of Cardiology Open access 12 Apr 2007 804
50 Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions Rossella Marullo, Erica Werner, Natalya P. Degtyareva et al. · PLoS ONE Open access 19 Nov 2013 801

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.